Home - Oncology Central

26 JUL 2021 CLINICAL TRIALS

Top 3 drug approvals in oncology: July 2021

25 JUL 2021 CLINICAL TRIALS

Design of the NeoADAURA clinical study: Osimertinib treatment before surgery in patients with NSCLC with a mutation in the EGFR gene

23 JUL 2021 CLINICAL TRIALS

RATIONALE 311: tislelizumab plus concurrent chemoradiotherapy for localized esophageal squamous cell carcinoma

22 JUL 2021 DRUG APPROVALS

UK’s NICE recommend pemigatinib (Pemazyre®) for FGFR2+ cholangiocarcinoma

21 JUL 2021 CLINICAL TRIALS

Overcoming data flow challenges in cell therapy trials: an interview with Olivier Saulin

21 JUL 2021 JOURNAL ARTICLES

Journal Content

10 FEB 2021Research Article / Future Oncology
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib in...
9 FEB 2021Review / Future Oncology
Platinum ineligibility in squamous cell carcinoma of the head and neck: consensus...
19 JAN 2021Research Article / Future Oncology
Nomograms to predict lung metastasis probability and lung metastasis subgroup survival in...
24 JUN 2021Clinical Trial Protocol / Future Oncology
Phase I dose-escalation study of NKTR-255 (IL-15 agonist) for natural killer cell...
10 JUN 2021Research Article / Future Oncology
Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck...
16 JUN 2021Review / Future Oncology
Use of real-world evidence for oncology clinical decision making in emerging economies

Featured

14 JUL 2021 SPOTLIGHT

Spotlight on clinical trials

24 FEB 2021 IN FOCUS

In Focus: GioTag

15 FEB 2021 IN FOCUS

In Focus: INSIGHT MM

24 DEC 2020 CHEMOTHERAPY / WEBINAR

Panel discussion: real-world data in clinical trials

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/11/5-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

9 NOV 2020
BIOMARKERS
/ PODCAST 
OCTalks: Comprehensive Genomic Profiling

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/11/in-association-with-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

9 NOV 2020
IN FOCUS 
In Focus: Comprehensive Genomic Profiling

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/10/Untitled-design-10-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="FGFR2" /> 

21 OCT 2020
CLINICAL TRIALS
/ PODCAST 
OCTalks: targeting FGFR2 in advanced cholangiocarcinoma

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/06/840x470-25-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

25 SEP 2020
DRUG APPROVALS
/ WEBINAR 
Panel discussion: past, present and future of immuno-oncology

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/09/Untitled-design-34-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="COVID-19 ethics" /> 

8 SEP 2020
CLINICAL TRIALS
/ PODCAST 
OCTalks: the ethical impact of COVID-19 on the cancer field

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/04/580x580-8-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

8 AUG 2020
IN FOCUS 
In Focus: coronavirus

Must Watch

26 MAY 2021 LUNG / VIDEO

Afatinib in NSCLC with uncommon EGFR mutations

25 MAY 2021 CLINICAL TRIALS / VIDEO

Sequential afatinib and osimertinib in NSCLC patients

30 MAR 2021 CLINICAL TRIALS / VIDEO

Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer: a patient perspective of the ARAMIS trial

24 DEC 2020 CHEMOTHERAPY / WEBINAR

Panel discussion: real-world data in clinical trials

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/10/Untitled-design-64-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="Managing colorectal cancer patients" /> 

2 OCT 2020
COLORECTAL
/ VIDEO 
Managing colorectal cancer patients in the COVID-19 era

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/06/840x470-25-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

25 SEP 2020
DRUG APPROVALS
/ WEBINAR 
Panel discussion: past, present and future of immuno-oncology

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/07/Capture-1-415x280.jpg" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

30 JUL 2020
OPINION
/ VIDEO 
Overcoming the challenges of precision medicine: an interview with Emily Leproust (Twist Bioscience)

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/06/580x580-61-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

1 JUN 2020
CLINICAL TRIALS
/ VIDEO 
ASCO20 virtual annual meeting: Editors’ highlights

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/04/580x580-35-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

29 APR 2020
EVENTS COVERAGE
/ VIDEO 
AACR20 Virtual Annual Meeting I: Editors' highlights from day 2

<img width="415" height="280" src="https://www.oncology-central.com/wp-content/uploads/2020/04/580x580-32-415x280.png" class="attachment-post-thumb size-post-thumb wp-post-image" alt="" /> 

28 APR 2020
EVENTS COVERAGE
/ VIDEO 
AACR20 Virtual Annual Meeting I: Editor's highlights from day 1

Top 3 drug approvals in oncology: July 2021

Design of the NeoADAURA clinical study: Osimertinib treatment before surgery in patients with NSCLC with a mutation in the EGFR gene

RATIONALE 311: tislelizumab plus concurrent chemoradiotherapy for localized esophageal squamous cell carcinoma

UK’s NICE recommend pemigatinib (Pemazyre®) for FGFR2+ cholangiocarcinoma

Overcoming data flow challenges in cell therapy trials: an interview with Olivier Saulin

Top 5 Future Oncology articles – July 2021

The power of precision medicine in bladder cancer: an interview with Dr Catherine Taylor

What tucatinib means for oncologists and their patients: an interview with Erika Hamilton

Panel discussion: how I treat metastatic HER2-positive breast cancer

Journal Content

Featured

Spotlight on clinical trials

In Focus: GioTag

In Focus: INSIGHT MM

Panel discussion: real-world data in clinical trials

OCTalks: Comprehensive Genomic Profiling

In Focus: Comprehensive Genomic Profiling

OCTalks: targeting FGFR2 in advanced cholangiocarcinoma

Panel discussion: past, present and future of immuno-oncology

OCTalks: the ethical impact of COVID-19 on the cancer field

In Focus: coronavirus

Must Watch

Afatinib in NSCLC with uncommon EGFR mutations

Sequential afatinib and osimertinib in NSCLC patients

Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer: a patient perspective of the ARAMIS trial

Panel discussion: real-world data in clinical trials

Managing colorectal cancer patients in the COVID-19 era

Panel discussion: past, present and future of immuno-oncology

Overcoming the challenges of precision medicine: an interview with Emily Leproust (Twist Bioscience)

ASCO20 virtual annual meeting: Editors’ highlights

AACR20 Virtual Annual Meeting I: Editors' highlights from day 2

AACR20 Virtual Annual Meeting I: Editor's highlights from day 1

Office info

Journal Content

Featured

Must Watch

What's Trending?